Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)
- PMID: 35773622
- PMCID: PMC9244878
- DOI: 10.1186/s12877-022-03191-4
Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)
Abstract
Background: Old age is one of the most important risk factors for severe COVID-19. Few studies have analyzed changes in the clinical characteristics and prognosis of COVID-19 among older adults before the availability of vaccines. This work analyzes differences in clinical features and mortality in unvaccinated very old adults during the first and successive COVID-19 waves in Spain.
Methods: This nationwide, multicenter, retrospective cohort study analyzes unvaccinated patients ≥ 80 years hospitalized for COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry). Patients were classified according to whether they were admitted in the first wave (March 1-June 30, 2020) or successive waves (July 1-December 31, 2020). The endpoint was all-cause in-hospital mortality, expressed as the case fatality rate (CFR).
Results: Of the 21,461 patients hospitalized with COVID-19, 5,953 (27.7%) were ≥ 80 years (mean age [IQR]: 85.6 [82.3-89.2] years). Of them, 4,545 (76.3%) were admitted during the first wave and 1,408 (23.7%) during successive waves. Patients hospitalized in successive waves were older, had a greater Charlson Comorbidity Index and dependency, less cough and fever, and met fewer severity criteria at admission (qSOFA index, PO2/FiO2 ratio, inflammatory parameters). Significant differences were observed in treatments used in the first (greater use of antimalarials, lopinavir, and macrolides) and successive waves (greater use of corticosteroids, tocilizumab and remdesivir). In-hospital complications, especially acute respiratory distress syndrome and pneumonia, were less frequent in patients hospitalized in successive waves, except for heart failure. The CFR was significantly higher in the first wave (44.1% vs. 33.3%; -10.8%; p < 0.001) and was higher among patients ≥ 95 years (54.4% vs. 38.5%; -15.9%; p < 0.001). After adjustments to the model, the probability of death was 33% lower in successive waves (OR: 0.67; 95% CI: 0.57-0.79).
Conclusions: Mortality declined significantly between the first and successive waves in very old unvaccinated patients hospitalized with COVID-19 in Spain. This decline could be explained by a greater availability of hospital resources and more effective treatments as the pandemic progressed, although other factors such as changes in SARS-CoV-2 virulence cannot be ruled out.
Keywords: 80 and over; Aged; COVID-19; Comorbidity; Complications; Epidemiology; Morbidity; Mortality; SARS-CoV-2; Spain.
© 2022. The Author(s).
Similar articles
-
Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry.J Gen Intern Med. 2021 Oct;36(10):3080-3087. doi: 10.1007/s11606-021-07066-z. Epub 2021 Aug 11. J Gen Intern Med. 2021. PMID: 34379281 Free PMC article.
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry.Sci Rep. 2023 Oct 18;13(1):17731. doi: 10.1038/s41598-023-42735-5. Sci Rep. 2023. PMID: 37853011 Free PMC article.
-
Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain.J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e28-e37. doi: 10.1093/gerona/glaa243. J Gerontol A Biol Sci Med Sci. 2021. PMID: 33103720 Free PMC article.
-
Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemic.Glob Health Med. 2022 Aug 31;4(4):204-209. doi: 10.35772/ghm.2022.01033. Glob Health Med. 2022. PMID: 36119783 Free PMC article. Review.
-
Obesity as a Risk Factor for Severe COVID-19 in Hospitalized Patients: Epidemiology and Potential Mechanisms.Healthcare (Basel). 2022 Sep 22;10(10):1838. doi: 10.3390/healthcare10101838. Healthcare (Basel). 2022. PMID: 36292285 Free PMC article. Review.
Cited by
-
Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center in Herat, Afghanistan.PLOS Glob Public Health. 2023 Aug 24;3(8):e0001687. doi: 10.1371/journal.pgph.0001687. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37619213 Free PMC article.
-
Differences in clinical characteristics and quantitative lung CT features between vaccinated and not vaccinated hospitalized COVID-19 patients in Italy.Ann Intensive Care. 2023 Apr 3;13(1):24. doi: 10.1186/s13613-023-01103-2. Ann Intensive Care. 2023. PMID: 37010706 Free PMC article.
-
Clinical characteristics and predictors of complications and mortality in hospitalized octogenarian patients with COVID-19: an ambispective study.Eur Geriatr Med. 2024 Oct;15(5):1477-1487. doi: 10.1007/s41999-024-01063-1. Epub 2024 Oct 19. Eur Geriatr Med. 2024. PMID: 39425809 Free PMC article.
-
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.Viruses. 2023 Aug 30;15(9):1839. doi: 10.3390/v15091839. Viruses. 2023. PMID: 37766248 Free PMC article.
-
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.Circulation. 2023 Jun 20;147(25):1891-1901. doi: 10.1161/CIRCULATIONAHA.123.063901. Epub 2023 May 8. Circulation. 2023. PMID: 37154020 Free PMC article. Clinical Trial.